(Q70558158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTG (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

J Cassidy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M A Graham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

W Ten Bokkel Huinink

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

C McDaniel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

A Setanoians

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

E M Rankin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

D J Kerr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

S B Kaye

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

395-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686154

12 October 2019

exact match

0 references

cites work

Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8431974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8431974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelines. EORTC Pharmacokinetics and Metabolism Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8431974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00686154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8431974%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference